A passion for outthinking cancer
Eric, Associate Director at Merrimack
Our collaborations

Innovation doesn't happen alone.
Learn more about teaming with Merrimack.

Learn more

A passion for outthinking cancer

News

View all news
November 08, 2017

Merrimack Reports Third Quarter 2017 Financial Results

Read more
November 01, 2017

Merrimack Announces Timing of Third Quarter 2017 Investor Conference Call

Read more
October 30, 2017

Merrimack Receives Orphan Drug Designation for MM-121 for the Treatment of Heregulin Positive Non-small Cell Lung Cancer

Read more
October 13, 2017

Merrimack Commences Tender Offer for Any and All of its Outstanding 4.50% Convertible Senior Notes Due 2020

Read more

Social Media

Follow us on Twitter

November 23, 2017
@MerrimackPharma
We're grateful for the inspiration of those who fight everyday for a world without #cancer. From our family to your… http://Cfl4D4FioL

November 20, 2017
@MerrimackPharma
Merrimack is working to help patients through a diversified, targeted clinical-stage pipeline. #oncology… http://HyayQICInq